INVA Q4 2020 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$90M+19.1% YoY

Gross Profit

$90M99.8% margin

Operating Income

$85M93.7% margin

Net Income

$54M59.6% margin

EPS (Diluted)

$0.48

QoQ Revenue Growth

+2.0%

Cash Flow

Operating Cash Flow

$85M

Free Cash Flow

$85M

Stock-Based Comp.

$447,000

Balance Sheet

Total Assets

$1000M

Total Liabilities

$392M

Stockholders' Equity

$540M

Cash & Equivalents

$246M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$90M	$76M	+19.1%
Gross Profit	$90M	$76M	+18.8%
Operating Income	$85M	$74M	+15.1%
Net Income	$54M	$46M	+17.3%